Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs NewcelX Ltd. (NCEL)

Fractyl Health, Inc. and NewcelX Ltd. are both Biotechnology companies. NewcelX Ltd. is the larger, with a market value of $15.6M against $11.9M — 1.3× the size. Across the 9 metrics below, Fractyl Health, Inc. leads on 5 and NewcelX Ltd. on 4.

Valuation

Metric GUTS NCEL Biotechnology median
P/E n/m n/m 10.26
P/S 127.89 n/m 9.18
P/B n/m 5.09 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.06 n/m 0.65
EV/Sales (51.61) n/m 8.98
Earnings yield (1,173.80%) (55.43%) (34.89%)
Free cash flow yield (697.71%) (15.95%) (24.52%)

Profitability

Metric GUTS NCEL Biotechnology median
Gross margin 46.24% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% 0.00% (50.12%)
Return on assets (146.75%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS NCEL Biotechnology median
Revenue growth (TTM) (22.50%) — 6.26%
EPS growth (last fiscal year) (14.81%) 11.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS NCEL Biotechnology median
Debt to equity (18.29) 0.06 0.00
Current ratio 3.15 0.40 4.89
Net debt to EBITDA 0.53 0.74 1.01

Dividend

Metric GUTS NCEL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS NCEL Biotechnology median
Market cap 11.88m 15.56m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack